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Abstract
The surface of the pulmonary alveolus is a major target for oxidant injury, and its proper repair following injury is
dependent on the proliferative response of the stem cells of the alveolar epithelium, the type 2 cells. In previous studies on the
mechanisms controlling this response, we have documented involvement of several components of the IGF system, and
mainly of the IGF binding protein-2 (IGFBP-2). We have provided evidence that this binding protein was associated with
inhibition of DNA synthesis of type 2 cells exposed to oxidants and that its expression was regulated mostly at the level of
transcription. In the present study, we focused on the factors involved in this regulation. From examination of the IGFBP-2
gene promoter sequence which revealed the presence of four potential binding sites for transcription factors of the NF-UB/
Rel family, we hypothesized that NF-UB might be involved in the transcriptional activation of IGFBP-2 in oxidant-exposed
cells. Data reported herein demonstrated that NF-UB activated IGFBP-2 promoter in transient transfection assays, and that
exposure of cells to hyperoxia was associated with accumulation of the active form of NF-UB. Using gel shift analysis, we
documented in O2-treated cells an increased binding to the four NF-UB binding sites. We also showed that accumulation of
NF-UB was associated with a decrease in the inhibitory molecule IUB-K. Based on the current knowledge on NF-UB
regulation, it is likely that in a number of situations associated with injury of lung alveolar epithelial cells signaling events
involving accumulation of NF-UB converge to activate IGFBP-2 and to block entry into S phase. ß 1999 Elsevier Science
B.V. All rights reserved.
1. Introduction
Among the structures of the respiratory system,
the surface of the alveolus represents a major target
for oxidant injury as it is directly exposed to the
various forms of reactive oxygen (O2) species which
can be produced by in£ammatory cells, by chemical
or pharmacological agents, as well as by environmen-
tal particles [1^3]. The epithelium of the alveolar
structure of the lung is composed of two types of
epithelial cells : type 1 and type 2 cells [4]. Only the
type 2 cells have the ability to replicate and they are
considered as the stem cells of this epithelium as they
can also undergo transition into type 1 cells [5^7].
Therefore, the process of type 2 cell proliferation is
a crucial element for lung homeostasis. Any impair-
ment in type 2 cell replication following oxidant
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injury may lead to an altered reparation of the res-
piratory epithelium [8,9].
Based on this knowledge, characterization of the
mechanisms involved in the block of alveolar epithe-
lial type 2 cell proliferation and in its reversibility
appears critical for the understanding and manage-
ment of many lung diseases associated with oxidative
stress. From several reports in the literature, it is
likely that events operating late in the G1 phase of
the cell cycle and/or during the G1/S transition play a
key role in type 2 cell regulation of proliferation [10^
12]. These events are certainly of importance in type
2 cells exposed to oxidants, as arrest before entry
into S phase represents an adequate response of all
cells when exposed to DNA damaging agents. This
response functions as a checkpoint control and is
associated with cell-cycle delays which provide op-
portunities for DNA repair before replication in or-
der to avoid irreparable mutations [13].
Focusing on the events controlling the entry into S
phase of type 2 alveolar epithelial cells, we have
documented in previous studies the involvement of
several components of the insulin-like growth factor
(IGF) system, and mainly of the IGF binding pro-
tein-2 (IGFBP-2) [14^16]. We have provided evi-
dence that this binding protein was associated with
inhibition of DNA synthesis in cells exposed to oxi-
dants and that its expression was regulated mostly at
the level of transcription. Examination of the
IGFBP-2 gene promoter revealed the presence of
several potential binding sites for transcription fac-
tors of the NF-UB/Rel family.
NF-UB is a family of related peptides which can be
divided into two groups based on di¡erences in struc-
tures and functions [17]. The ¢rst group includes p50
and the second p65. Members of both groups can
form multiple homo- or heterodimer complexes
such as p50-p65 heterodimers. NF-UB is an inducible
eukaryotic transcription factor which exists in an in-
active form in the cytoplasm of most cells where it is
bound to inhibitory proteins IUB [18,19]. NF-UB can
be activated in response to a number of factors in-
cluding viruses, bacteria, oxidants, and in£ammatory
cytokines [3,20]. These factors trigger the release
from IUB allowing migration of the heterodimer to
the nucleus where NF-UB binds to DNA and regu-
lates transcription of speci¢c genes [21]. The various
pathways leading to NF-UB activation implicate IUB
phosphorylation and degradation. At least two dif-
ferent inhibitors seem to be involved: IUB-K and
IUB-L [22]. Distinct modes of regulation as well as
distinct responses to various NF-UB inducers have
been recently reported for these proteins. So far, deg-
radation of IUB-K has been observed in all situations
of NF-UB activation. This was not found for IUB-L
[23]. IUB functions by inhibiting the DNA binding
and the nuclear uptake of associated DNA-binding
proteins. The mechanism of this inhibitory action
seems to be a direct binding of IUB to the nuclear
location signal of p65 [18].
A number of studies have shown that nuclear re-
tention and DNA binding of NF-UB are increased
following exposure to a large variety of components
which lead to an increased oxidant production. Also
recent works have suggested that NF-UB could be
involved in growth control [17,24]. Together with
the ¢nding that NF-UB binding sites were present
in IGFBP-2 promoter, these data prompted us to
ask whether NF-UB could play a role in the tran-
scriptional activation of IGFBP-2 in lung alveolar
epithelial cells growth-arrested by oxidant exposure.
In the present study, we provide data indicating that
NF-UB is able to activate the IGFBP-2 promoter.
We also document in O2-exposed cells an accumula-
tion of the active form of NF-UB as well as an in-
creased binding to the four NF-UB binding sites
present in the IGFBP-2 promoter. Mechanisms in-
volved in accumulation and activation of NF-UB
and IGFBP-2 with block of entry into S phase of
lung epithelial cells exposed to oxidative stress are
discussed.
2. Materials and methods
2.1. Cells, cell culture conditions
The type 2 cell line used in this study was derived
from rat lung neonatal type 2 cells by transfection
with SV40-T antigen gene and has been extensively
characterized [25]. Cells were grown in Earle’s MEM
(Gibco BRL, Grand Island, NY) supplemented with
4 mM glutamine, 50 U of penicillin/ml, 50 Wg of
streptomycin/ml, and 10% fetal bovine serum (FBS)
(Eurobio, France). For control conditions, cells were
cultured in a 5% CO2/95% air atmosphere at 37‡C.
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For hyperoxic conditions, they were cultured in 5%
CO2/95% O2 atmosphere at 37‡C. Under these hy-
peroxic conditions, cells ceased proliferation after
24 h O2, as previously described [11,14].
For proliferation studies, cells were plated at a
density of 2U104 cells/35 mm culture dish. Three
days later, the medium was changed and the cells
were placed either in control atmosphere or in hyper-
oxia for the indicated times. Cell number was deter-
mined by harvesting the cells with trypsin-EDTA
and counting them in triplicate using a hemocytom-
eter [26].
For the study of pyrrolidine dithiocarbamate
(PDTC) e¡ects, proliferative cells (50% con£uence)
were incubated in a medium containing 1035 M or
1034 M of PDTC (Sigma, St. Louis, MO) and ex-
posed to 95% O2 for 12 h.
For each protocol, three or four independent ex-
periments were performed.
2.2. DNA transfection and in vivo transcription assay
For transfection experiments, the following plas-
mids were used. The IGFBP-2 promoter plasmid
p(31400/+12) IGFBP-2-LUC was constructed as
previously indicated [16]: it contains the fragment
of the rat IGFBP-2 promoter extending from
+12 bp relative to the start of transcription plus
1.4 kb of 5P-£anking sequence, ligated to a ¢re£y
luciferase reporter gene into plasmid pBL-LUC. In
addition, the fragment of IGFBP-2 promoter,
3580 bp to +12 bp, fused to the promoterless ¢re£y
luciferase reporter gene (a gift from Dr. Kuto, Basel,
Switzerland) was also used [27]. pRSVLUC (a gift
from Dr. Schneid, St. Antoine University, Paris,
France) contains the Rous sarcoma virus promoter/
enhancer fused to the luciferase reporter gene. pBL-
LUC is a promoterless plasmid. pSV40L-gal plasmid
expresses the Escherichia coli lacZ gene under the
control of SV40 promoter (a gift from Dr. Schneid),
and was used as an internal control to assess the
e⁄ciency of transfection. All plasmids were prepared
using plasmid extraction kits (Qiagen, Chatsworth,
CA).
Plasmids were introduced into cells using the lipo-
fectine method. Adherent cells (60% con£uent) were
washed twice with MEM and were incubated for 24 h
at 37‡C with 10 Wl lipofectine solution (1 mg/ml)
(Gibco BRL) and 3 ml of serum and antibiotic free
medium containing 5 Wg of luciferase plasmid and
1 Wg of pSV40L-gal plasmid. Cells were then washed
with MEM and incubated for 48 h under control
conditions or under hyperoxia in medium containing
10% FBS and 8 mM glutamine. At the end of this
incubation, cells were washed with cold PBS and
then harvested, and cellular extracts were prepared
by lysing the cells in 0.5 ml lysis solution (8 mM
MgCl2, 25 mM Tris pH 8, 1 mM dithiothreitol
(DTT), 1% Triton X-100, and 15% glycerol). Lucifer-
ase assays were performed using an equal volume of
extracts. Luciferase activity was measured immedi-
ately after addition of 100 Wl substrate solution
(0.5 mM ATP, 0.5 mM D-luciferin) in a luminometer
(LKB, Gaithersburg, MD). Under these experimen-
tal conditions, initial studies showed that the activ-
ities measured in the cell extracts were within the
linear range. Luciferase activity was then normalized
for transfection e⁄ciency as determined by L-galac-
tosidase activity and L-galactosidase staining. For
each reporter plasmid, at least three independent
transfections were performed.
Expression vectors p(CMV-p50) and p(CMV-p65)
for the two subunits of NF-UB transcription factor,
p65 and p50, coupled to the cytomegalovirus pro-
moter (a gift from Dr. P. Baeuerle, Tularik, San
Francisco, CA) were also used for co-transfection
experiments with the construct p(31400/+12)
IGFBP-2-LUC described above. For these experi-
ments, cells were transfected using 10 Wl of lipofec-
tine reagent in 3 ml of serum and antibiotic free
medium. Each 100 mm dish received 5 Wg of reporter
plasmid and variable amounts of expression vectors
(the two expression vectors were added at the same
quantities). In addition, 1 Wg of L-galactosidase ex-
pression vector was used with each dish.
2.3. Nuclear extract preparation and gel mobility shift
assay
2.3.1. Nuclear extract preparation
Nuclear extracts were prepared from type 2 cells
by the method of Schreck et al. with minor modi¢-
cations after treatment with or without O2 [28]. After
three washings in cold PBS, cells were mechanically
detached, and pelleted by centrifugation at 2000Ug
for 5 min. The cellular pellet was volumed, resus-
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pended in 3 vols. of solution A (10 mM HEPES,
1.5 mM MgCl2, 10 mM KCl, 0.5 mM DTT, 1%
NP-40) with freshly added protease inhibitors (1 Wg/
ml leupeptin, 5 Wg/ml aprotinin, and 1 mM phenyl-
methylsulfonyl £uoride) and lysated for 5 min at 4‡C
in agitation. Membrane lysis was accomplished by
the presence in solution A of 1% NP-40. The nuclei
were then collected by centrifugation at 2000Ug for
5 min and the supernatant (cytosolic extract) was
stored at 380‡C until analysis by electrophoretic mo-
bility shift assays. The nuclear pellet was resuspended
in 1 vol. of solution B (20 mM HEPES, 1.5 mM
MgCl2, 300 mM KCl, 0.5 mM DTT, 0.2 mM
EDTA, 25% glycerol) with freshly added protease
inhibitors as described above and agitated vigorously
at 4‡C for 30 min. Nuclear debris were collected by
centrifugation at 15 000Ug for 30 min, and the
supernatant (nuclear extract) was stored at 380‡C
until analysis by electrophoretic mobility shift assays.
The protein concentrations were determined using
the Bio-Rad Protein Assay kit (Bio-Rad, Richmond,
CA).
2.3.2. Electrophoretic mobility shift assays
Electrophoretic mobility shift assays (EMSA) were
performed using NF-UB probes corresponding to
NF-UB binding sequences present in the rat
IGFBP-2 promoter. Five di¡erent NF-UB oligonu-
cleotides were obtained commercially (Oligo-Express,
Paris) and used in the EMSA. They included the
recognition sites for the four putative NF-UB sites
present in the IGFBP-2 promoter [27]: NF-UB1 (5P-
TCTATGGAATCTCCAAGCTT-3P), NF-UB2 (5P-
GGGAAGGGAGACGCCTCACT-3P), NF-UB3 (5P-
AGTAGGGGGACCCGCCGAAT-3P), NF-UB4 (5P-
AAGGAGGCGTCTCCCGCGGT-3P) and a mu-
tated NF-UB1 sequence (5P-TCTATTTAATCTC-
CAAGCTT-3P). EMSA were also performed using
NF-1 probe (5P-AAGAAAAACCGTTCCTACCA-
TACTAA-3P) (a gift from Dr. De Keyzer, Cochin
Hospital, Paris, France). The double-stranded probes
were obtained from annealing of two synthesized oli-
gonucleotides and end-labeled using T4 polynucleo-
tide kinase in the presence of [Q-32P]ATP. Unincor-
porated nucleotides were removed by ¢ltration
through a Bio-spin column (Bio-Rad). Binding reac-
tion was carried out in 20 Wl binding mixture (20 mM
HEPES, 0.1 mM EDTA, 50 mM NaCl, 50 mM KCl,
5 mM MgCl2, 4 mM spermidine, 2 mM DTT, 100 Wg/
ml albumin, 17.5% glycerol), containing 1 Wg of the
competitor poly(dI-dC) and 4 Wg of nuclear proteins
[28]. After addition of nuclear extracts, reaction was
allowed for 15 min at 4‡C. Thereafter, 15 000 cpm of
the NF-UB probe were added and the incubation
continued for 30 min at 4‡C. The competition experi-
ments were performed using increasing amounts of
unlabeled speci¢c NF-UB probe (10-, 100-, 200-fold
molar excess) and non-speci¢c poly(dI-dC) (1 Wg),
which were mixed with extracts before the addition
of the labeled DNA probe. For supershift experi-
ments, extracts were preincubated overnight at 4‡C
with 1 Wg of 3 Wg of monoclonal anti-NF-UB anti-
body (p65 subunit, Boehringer Mannheim, Ger-
many) before the labeled DNA probe was added.
Samples were fractionated by electrophoresis on 5%
non-denaturing polyacrylamide gel in 1UTBE
(10 mM Tris, 9 mM boric acid, 0.1 mM EDTA),
which had been pre-electrophoresed for 1 h at
100 V. Gels were run at 150 V for 2.5 h. Following
electrophoresis, gels were dried under vacuum at
80‡C and exposed to X-ray Hyper¢lm at room tem-
perature. Results were quanti¢ed by laser scanning
densitometry of the autoradiographs.
2.4. Protein studies
Cells were washed 3 times with cold PBS and lysed
by addition of 200 Wl lysis bu¡er (250 mM NaCl,
50 mM HEPES pH 7.0, 5 mM EDTA, 1 mM
DTT, 0.1% nonidet NP-40, 10 Wg/ml leupeptin,
10 Wg/ml apoprotinin, 50 Wg/ml phenylmethylsulfonyl
£uoride, 2 mM sodium pyrophosphate, 1 mM so-
dium orthovanadate) [12]. The lysates were incu-
bated at 4‡C overnight and clari¢ed by centrifuga-
tion at 10 000Ug for 10 min at 4‡C. Equal quantities
of proteins were loaded for each experimental con-
dition and, after boiling, the samples were analyzed
on SDS-PAGE (11% polyacrylamide) under reducing
conditions.
Western blots were prepared by electrotransferring
the proteins onto 0.45 Wm nitrocellulose membranes
(NC; Bio-Rad) for 1 h at 130 V. Immunoblotting
was performed by ¢rst saturating the NC sheet for
4 h at room temperature in PBS containing 0.2%
Tween (PBS-T) and 10% powdered milk. This was
followed by incubation with diluted antiserum in 5%
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milk-PBS for 20 h at 4‡C. The antisera used were the
following: monoclonal anti-NF-UB antibody (p65
subunit, Boehringer Mannheim), monoclonal anti-
IUB-K antibody (a gift from Dr. A. Weil, Pasteur
Institute, Paris, France). The membranes were then
washed 3 times in PBS-T bu¡er and incubated for 1 h
at 37‡C with horseradish peroxidase conjugated goat
antimouse immunoglobulin G (Amersham, UK), di-
luted 1/6000 in milk-PBS. The membranes were then
washed 3 times in PBS-T, after which they were in-
cubated for 1 min at room temperature in chemilu-
minescence reaction detection reagents (ECL West-
ern blotting, Amersham). The membranes were then
exposed to autoradiography ¢lm (Hyper¢lm-ECL,
Amersham).
2.5. Statistical methods
Results are reported as mean þ S.E.M. Data were
analyzed using ANOVA followed, when adapted, by
Bonferroni t-test for multiple comparisons against
control conditions. Signi¢cance is assigned for
P6 0.05.
3. Results
3.1. Activation of IGFBP-2 promoter in cells exposed
to hyperoxia
To determine the e¡ects of hyperoxia on the pro-
moter activity of the IGFBP-2 gene, transfection ex-
periments were performed. Type 2 cells were co-
transfected with pairs of expression vectors, includ-
ing one that conveys expression of luciferase gene
and one that conveys expression of E. coli lacZ
gene. One set of cells was transfected with the control
pLUC promoterless construct. The second set of cells
was transfected with pRSVLUC construct. The third
set of cells was transfected using luciferase gene
transcribed from the IGFBP-2 promoter with 1.4 kb
of 5P-£anking sequence IGFBP-2: p(31400/+12)
IGFBP-2-LUC. Transfection e⁄ciency evaluated by
cell blue staining was found to £uctuate between 10
and 20%. For each set, cells were incubated under
normoxia or hyperoxia for 48 h. As previously re-
ported, exposure of type 2 cells to hyperoxia led to a
rapid inhibition of cell proliferation [11,12,14]. In-
deed, after 48 h O2, no increase in cell number could
be detected (data not shown). After preparation of
cellular extracts luciferase and L-galactosidase activ-
ity assays were carried out. The luciferase activity in
extracts of cells transfected with the promoterless
construct did not exceed the apparatus background
level. Using the pRSVLUC construct, no di¡erences
in luciferase activity could be observed in extracts of
cells cultured under either normoxia or hyperoxia
(data not shown). As reported in Fig. 1, exposure
to O2 was found to induce luciferase activity of the
p(31400/+12) IGFBP-2-LUC construct, indicating
that IGFBP-2 promoter was active under hyperoxic
conditions.
3.2. IGFBP-2 promoter contains functional NF-UB
binding sites
Examination of the IGFBP-2 promoter revealed
the presence of four sequences that match the NF-
UB binding consensus: NF-UB binding consensus:
GGGRNNYYCC, where R = purine, Y = pyrimidine
and N = any nucleotide. These sequences in the
IGFBP-2 promoter are the following: nucleotides
31305 bp to 31297 bp: GGAATCTCC; 31072 bp
to 31063 bp: GGGAGACGCC; 3267 bp to 3258
bp: GGGGGACCCG; 373 bp to 364 bp:
GGCGTCTCCC.
Fig. 1. Activity of IGFBP-2 promoter in type 2 cells. Type 2
cells were co-transfected with the plasmid p(31400/+12)
IGFBP-2-LUC and the plasmid conveying expression of E. coli
lacZ gene, as described in Section 2. The cells were then cul-
tured in either control or hyperoxia conditions (48 h under 95%
O2). Luciferase assays were performed using an equal amount
of proteins and luciferase activity was then normalized for
transfection e⁄ciency, as determined by L-galactosidase activity.
IGFBP-2 promoter activity values on the graph correspond to
the ratio luciferase activity/L-galactosidase activity. The mean
and S.E.M. for three independent experiments performed in
triplicate are shown (*P6 0.05).
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To determine whether NF-UB binding was in-
volved in the transcriptional regulation of IGFBP-
2, p(31400/+12) IGFBP-2-LUC construct was co-
transfected with increasing amounts of p50 and p65
expressing plasmids into type 2 cells cultured under
control conditions. As shown in Fig. 2, expression of
p50 and p65 stimulated luciferase activity. These re-
sults indicated that NF-UB was able to activate
IGFBP-2 promoter in a concentration-dependent
fashion and therefore suggested a role of NF-UB
binding sites in the response. No changes in lucifer-
ase activity could be found when the p50 and p65
expressing plasmids were co-transfected with the pro-
moterless ¢re£y luciferase reporter gene pBL-LUC
(Fig. 2).
3.3. Involvement of NF-UB binding sites in the
transcriptional activation of IGFBP-2 in
oxidant-exposed cells
To determine the involvement of the di¡erent pu-
tative NF-UB binding sites in the transcriptional reg-
ulation of IGFBP-2 promoter, gel mobility shift as-
says were performed with the four NF-UB double-
stranded oligonucleotides identical to the sequences
observed in the IGFBP-2 promoter. Gel retardation
Fig. 2. NF-UB activates the IGFBP-2 promoter. p(31400/+12)
IGFBP-2-LUC or pBL-LUC constructs (5 Wg) were co-trans-
fected with increasing amounts of NF-UB expressing plasmids
(pCMV-50 and pCMV-65) into type 2 cells, as described in Sec-
tion 2. The luciferase values, normalized for L-galactosidase,
were expressed as percentage over the activity obtained in the
absence of NF-UB plasmids.
Fig. 3. E¡ects of O2 on the activity of the four NF-UB sites. (A) Nuclear proteins were extracted from cells cultured under control
conditions (air) or under hyperoxia (95% O2) for 6 h, 12 h, 24 h or 48 h. 15 000 cpm of the four Q-32P end-labeled NF-UB probes
were incubated without protein or with 4 Wg of nuclear extracts and followed by gel retardation assays as described in Section 2. The
DNA-protein complexes formed are indicated by an arrow. The uncomplexed DNA probes are shown on the bottom. (B) Nuclear
proteins were extracted from cells cultured under hyperoxia (95% O2) for 12 h. 15 000 cpm of Q-32P end-labeled NF-UB1 probe was in-
cubated in the presence of 4 Wg of nuclear extracts without or with the monoclonal antibody anti-p65 NF-UB subunit (1 Wg or 3 Wg).
Gel retardation assays were then performed as described in Section 2. The DNA-protein complexes formed are indicated by an arrow.
The uncomplexed DNA probes are shown on the bottom.
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analysis revealed that these oligonucleotides were
able to bind nuclear factors and that the binding
increased in O2-treated cells. No di¡erence in the
binding of NF-UB nuclear factors could be detected
between the di¡erent sites, the experiments being per-
formed each time with the same nuclear extracts and
run on the same gel as shown in Fig. 3A. Moreover,
for the di¡erent NF-UB binding sites the maximal
binding was observed in the experimental conditions
where the cells were exposed to hyperoxia for 12 h.
Formation of the DNA-protein complexes was fur-
ther studied in the presence of antibodies directed
against p65 NF-UB subunits. A supershift was ob-
served after addition of anti-p65 antibody, with an
increased intensity of the upper band in the presence
of increasing amounts of antibody (Fig. 3B) [29,
30].
From data reported in Fig. 3A it appeared that the
activation of the four NF-UB binding sites may be
similar in cells exposed to hyperoxia. To give more
support to these results, co-transfection experiments
were performed using p(31400/+12) IGFBP-2-LUC
construct containing the two putative NF-UB sites
located in the distal part of the promoter (at position
31305/31297 and 31072/31063, respectively) and
the two putative NF-UB sites located in the proximal
part of the promoter (at position 3267/3258 and
373/364, respectively), and using p(3580/+12)
IGFBP-2-LUC construct that contains only the two
proximal NF-UB sites. The promoter activity of the
construct containing only the two proximal NF-UB
sites was still inducible by O2 albeit at a lower level
compared to the luciferase activity obtained using the
p(31400/+12) IGFBP-2-LUC construct which con-
tains the four NF-UB sites with a 39% reduction of
activity (Fig. 4). These experiments indicated that the
distal and the proximal parts of the IGFBP-2 pro-
moter, each containing two putative NF-UB binding
sites, seemed to contribute to a similar extent to the
e¡ect of hyperoxic treatment on IGFBP-2 promoter
activity.
To con¢rm activation of NF-UB in oxidant-ex-
posed cells, the speci¢city of gel-shift complexes
was assessed using competition experiments. When
nuclear proteins were incubated in the presence of
a 10^200-fold molar excess of unlabeled oligonucleo-
tides, the binding was competitively blocked, whereas
incubation with unlabeled oligonucleotides corre-
sponding to the irrelevant sequence poly(dI-dC) did
not modify formation of the complexes. In the results
shown in Fig. 5A, experiments were performed using
oligonucleotides corresponding to NF-UB1. Similar
results were obtained using oligonucleotides corre-
sponding to the other putative binding sites (data
not shown).
To verify that DNA requirements for binding of
factors to the region of the IGFBP-2 promoter de-
¢ned by the NF-UB oligonucleotide were similar to
those exhibited by members of the NFUB family, a
double-strand oligonucleotide that incorporated a
2-base pair mutation in the NF-UB1 oligonucleotide
Fig. 4. E¡ects of hyperoxia on IGFBP-2 promoter constructs
containing di¡erent numbers of NF-UB sites. Type 2 cells were
co-transfected with p(31400/+12) IGFBP-2-LUC construct con-
taining the two putative NF-UB sites located in the distal part
of the promoter (at position 31305/31297 and 31072/31063,
respectively) and the two putative NF-UB sites located in the
proximal part of the promoter (at position 3267/3258 and
373/364, respectively), or with p(3580/+12) IGFBP-2-LUC
construct that contains only the two proximal NF-UB sites, in
association with the plasmid conveying expression of E. coli
lacZ gene, as described in Section 2. The cells were then cul-
tured under either control or hyperoxic conditions (48 h O2).
Luciferase assays were performed using an equal amount of
proteins and luciferase activity was normalized for transfection
e⁄ciency, as determined by L-galactosidase activity. The values
obtained under hyperoxia were expressed as percentage over the
activity obtained under control conditions. The mean and
S.E.M. for three independent experiments performed in tripli-
cate are shown.
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was synthesized: NF-UB1 (5P-TCTATGGAATCTC-
CAAGCTT-3P) was changed to (5P-TCTATTTA-
ATCTCCAAGCTT-3P). This GG to TT mutation
abolishes binding of an NF-UB-like factor to the ma-
jor histocompatibility class II-associated invariant
chain gene [31]. When this mutant oligonucleotide,
Mut NF-UB1, was radiolabeled and used in gel mo-
bility shift assay, it failed to bind to nuclear proteins
as compared with the wild type NF-UB1 sequence
(Fig. 5B). Thus a mutation known to inhibit the
binding of NF-UB1 inhibits the ability of nuclear ex-
tracts to bind to a target sequence in the IGFBP-2
promoter.
To further con¢rm the speci¢city of activation of
NF-UB by oxidant, gel shift was performed using an
oligonucleotide to which binding is invariant. For
this experiment, we used the ubiquitous nuclear fac-
tor 1 (NF-1) oligonucleotides [32,33]. Gel retardation
analysis revealed that the binding was similar in the
nuclear extracts obtained from cells cultured under
normoxia or under hyperoxia for various durations
(Fig. 5C).
3.4. E¡ect of hyperoxia on NF-UB protein
To further substantiate a role for NF-UB in the
transcriptional activation of IGFBP-2 in oxidant-ex-
posed cells, NF-UB protein level was studied. Nu-
clear extracts were prepared from exponentially
growing cells and from cells exposed to hyperoxia
and analyzed by immunoblotting with anti-p65 anti-
body. As shown in Fig. 6A, exposure to hyperoxia
led to a rapid accumulation of p65 in the nuclear
extracts. This was observed after only 6 h of O2
Fig. 5. Gel mobility shift assays using NF-UB or NF-1 probes: competition experiments and O2 speci¢city studies. (A,B) Nuclear pro-
teins were extracted from cells cultured under hyperoxia (95% O2). 15 000 cpm of Q-32P NF-UB1 (lanes 1^6) or Mut NF-UB1 (lane 7)
probe were incubated with 4 Wg of nuclear extracts with increasing amounts of unlabeled NF-UB probe (10-, 100-, 200-fold molar ex-
cess) (lanes 2^4) or poly(dI-dC) (lane 5) as competitors and followed by gel retardation assays as described in Section 2. The DNA-
protein complexes formed are indicated by an arrow. The uncomplexed DNA probes are shown on the bottom. Similar results were
obtained upon repetition of the experiment. (C) Nuclear proteins were extracted from cells cultured under control conditions (air) or
under hyperoxia (95% O2) for 6 h, 12 h, or 24 h. 15 000 cpm of the Q-32P end-labeled NF-1 probe was incubated without protein or
with 4 Wg of nuclear extracts and followed by gel retardation assays as described in Section 2. The DNA-protein complexes formed
are indicated by an arrow. The uncomplexed DNA probes are shown on the bottom. Similar results were obtained upon repetition of
the experiment.
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treatment, con¢rming that the NF-UB factor was
rapidly translocated from the cytoplasm to the nu-
cleus of type 2 cells cultured under hyperoxia.
To determine whether accumulation of NF-UB in
oxidant-treated cells involved de novo protein syn-
thesis, cellular protein extracts were prepared from
control or O2-exposed cells cultured in the presence
of an inhibitor of protein synthesis, cycloheximide
(10 Wg/ml) for 6 h, and analyzed by immunoblotting
with anti-p65 antibody. Results are shown in Fig.
6B. Exposure to oxidant was associated with in-
creased levels of p65 compared to the levels observed
in exponentially growing cells, and addition of cyclo-
heximide was not associated with a decrease in the
amounts of p65. These results indicate that oxidant-
induced activation of NF-UB did not involve de novo
NF-UB protein synthesis. This is further supported
by the results obtained in control cells showing a
low level of p65 in conditions when cells were cul-
tured without protein synthesis inhibitor and a dra-
matic induction upon treatment with cycloheximide.
Further evidence for the role of NF-UB in the tran-
scriptional regulation of the IGFBP-2 promoter by
oxidants was provided by the use of PDTC [34,35].
PDTC is a molecule which can suppress radical pro-
duction by chelating metal very e⁄ciently. We show
in Fig. 7 that the level of nuclear protein p65 de-
creased in the presence of PDTC in a dose-dependent
manner, indicating that PDTC was able to inhibit
the e¡ects of hyperoxia on NF-UB activation. In ad-
dition, gel shift performed using NF-UB1 probe and
nuclear extracts from cells cultured under hyperoxia
Fig. 6. E¡ects of O2 and cycloheximide on nuclear NF-UB protein level. (A) Nuclear proteins were extracted from cells cultured under
air (control condition) or under hyperoxia (95% O2) for 6 h or 24 h, and analyzed by immunoblotting. Proteins were fractionated on
SDS-PAGE, transferred to nitrocellulose, and probed with the monoclonal antibody to the p65 subunit of NF-UB, as described in
Section 2. An autoradiogram of signals for the p65 subunit of NF-UB (65 kDa) is shown. The histogram shows a quantitative repre-
sentation of hybridization signals obtained from laser densitometric analysis of the exposed ¢lms. Results are expressed in arbitrary
densitometric units after normalization on the basis of control condition signal. (B) Proteins were extracted from cells cultured under
air (control condition), or under hyperoxia (95% O2) for 6 h or 24 h, in the absence or presence of cycloheximide (CHX). Proteins
were analyzed by immunoblotting. Samples were fractionated on SDS-PAGE, transferred to nitrocellulose, and probed with the mono-
clonal antibody to the p65 subunit of NF-UB, as described in Section 2. An autoradiogram of signals for the p65 subunit of NF-UB
(65 kDa) is shown. The histogram shows a quantitative representation of hybridization signals obtained from laser densitometric anal-
ysis of the exposed ¢lms. Results are expressed in arbitrary densitometric units after normalization on the basis of control condition
signal.
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for 12 h with or without PDTC indicated a decreased
binding in PDTC-treated cells (data not shown).
The increased accumulation of NF-UB in the nu-
clear fraction of O2-exposed cells led to suggest an
altered regulation of IUB with an increased degrada-
tion by oxidants. To test this hypothesis, abundance
of IUB-K was evaluated in the cytosolic extracts of
cells cultured under either control conditions or hy-
peroxia for 6 and 24 h. Results are presented in Fig.
8. Exposure to oxidants was associated with a de-
crease in the abundance of IUB-K, and this was de-
pendent on O2 treatment duration with a maximal
e¡ect at 24 h.
4. Discussion
In the present study, we have shown that oxidant
exposure of lung alveolar epithelial cells induced
transcriptional activation of IGFBP-2, a gene whose
expression has been reported to be associated with
inhibition of type 2 cell proliferation. Study of the
mechanisms involved provided evidence that NF-UB
may play a role in this process. Indeed, data pre-
sented herein demonstrated that NF-UB activated
IGFBP-2 promoter in transient transfection assays,
and that NF-UB was activated in O2-treated cells.
Moreover, gel shift analysis documented an increased
Fig. 7. E¡ects of pyrrolidine dithiocarbamate (PDTC) on nuclear NF-UB protein level. Proteins were extracted from cells cultured
under hyperoxia (95% O2) for 12 h, without or with 1035 M or 1034 M PDTC. Proteins were analyzed by immunoblotting. Samples
were fractionated on SDS-PAGE, transferred to nitrocellulose, and probed with the monoclonal antibody anti-p65 NF-UB subunit, as
described in Section 2. An autoradiogram of signals for the p65 subunit of NF-UB (65 kDa) is shown. The histogram shows a quanti-
tative representation of hybridization signals obtained from laser densitometric analysis of the exposed ¢lms. Results are expressed in
arbitrary densitometric units after normalization on the basis of condition without PDTC signal.
Fig. 8. E¡ects of O2 on IUB protein level. Proteins were extracted from cells cultured under air (control condition), or under hyper-
oxia (95% O2) for 6 h or 24 h. Proteins were analyzed by immunoblotting with anti-IUB-K antibody, as described in Section 2. An
autoradiogram of signals for IUB-K (37 kDa) protein is shown. The histogram shows a quantitative representation of hybridization
signals obtained from laser densitometric analysis of the exposed ¢lms. Results are expressed in arbitrary densitometric units after nor-
malization on the basis of control condition signal.
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binding to the NF-UB binding sites present in the
IGFBP-2 promoter in lung cells growth-arrested by
oxidants.
Our present results extend previous studies on the
mechanisms involved in the growth control of lung
alveolar epithelial cells. Using various modes of
block of type 2 cell proliferation including serum
deprivation and O2 treatment, we have shown that
inhibition of DNA synthesis observed under these
experimental conditions was associated with similar
induction of IGFBP-2, and that control of IGFBP-2
expression was exerted mostly at the level of tran-
scription [14^16]. IGFBP-2 is a member of the IGF
system which is known to play an important role
during the late part of the G1 phase of the cell cycle
[36]. Taken together, these data support the hypoth-
esis that common regulatory mechanisms are in-
volved in the growth arrest of lung epithelial cells
induced under various conditions, and suggest that
events operating late in the G1 phase of the cell cycle
play a key role in the regulation of type 2 cell pro-
liferation. To gain further insights into these mecha-
nisms, we focused on the factors which may partic-
ipate in the activation of IGFBP-2 promoter. From
analysis of the genomic sequence upstream from the
transcriptional start of IGFBP-2 which revealed the
presence of consensus binding sites for NF-UB, a
possibility has emerged that modulation of binding
of NF-UB to its cognate element in the IGFBP-2
promoter may control lung alveolar epithelial cell
proliferation. This hypothesis was sustained by the
current knowledge on the processes involved in the
activation of NF-UB. It is now well established that
NF-UB is an oxidative stress responsive transcription
factor, and that reactive O2 species play a key role in
its activation [20]. Moreover, the activation of NF-
UB has been shown to be blocked by a variety of
antioxidant components [35,37]. Oxidative injury
which results from an imbalance in oxidant-antioxi-
dant equilibrium in favor of oxidants can occur in
situations associated with high production of reactive
O2 species, such as hyperoxia [38]. It can also be
observed in a number of stress situations including
culture without serum. Indeed, an alteration in the
level of antioxidants and mainly of the glutathione
system has been documented in these conditions
[39,40]. Interestingly, Messina et al. indicated that
lymphocytes depleted of glutathione were blocked
in cell cycle progression before entry into S phase
suggesting a link between glutathione depletion and
cellular growth arrest late in G1 [41]. These various
studies give support to the hypothesis that common
mechanisms associated with the block of prolifera-
tion of lung alveolar epithelial cells exposed to oxi-
dants or to other situations such as serum depriva-
tion may involve oxidative stress and may participate
in the activation of NF-UB [42].
The IGFBP-2 gene contains four NF-UB binding
sites in the 5P-£anking region, and data reported
herein indicated that these sites were active under
O2 exposure, suggesting that NF-UB may be involved
in IGFBP-2 regulation. The observation that
IGFBP-2 promoter constituted a target for the ac-
tion of NF-UB was ¢rst supported by the co-trans-
fection experiments using p50 and p65 expression
vectors. A role of NF-UB in the transcriptional con-
trol of IGFBP-2 in O2-exposed cells was then docu-
mented using gel retardation assays; the four NF-UB
sites in the IGFBP-2 promoter seemed to be acti-
vated to a similar extent upon exposure to oxidants.
The precise involvement of the four putative NF-UB
binding sites is now under investigation.
The transcriptional activation of IGFBP-2 was
found to be associated with accumulation of NF-
UB in O2-treated cells, and results of the experiments
using cycloheximide argued against de novo protein
synthesis. These ¢ndings are consistent with the cur-
rent understanding of NF-UB activation. The mech-
anisms involved associate signal-dependent phos-
phorylation and ubiquitination of IUB at N-
terminal sites, which target the inhibitor for degra-
dation by the 26S proteasome. In turn, this proteo-
lytic event exposes subcellular localization motifs on
NF-UB that direct it to the nuclear compartment
[43,44]. Data reported herein are consistent with an
increased translocation of NF-UB to the nucleus
leading to an accumulation of NF-UB in the nuclear
extracts of cells exposed to hyperoxia. This is sus-
tained by the decrease in the abundance of IUB-K
found in the cytosolic extracts of O2-treated cells.
Additional evidence of NF-UB activation in oxi-
dant-exposed cells is supported by the results of ex-
periments using PDTC. Although the mode of action
of PDTC remains largely discussed, its e¡ect on NF-
UB activation has been reported in several studies to
be suppressive [43,44]. In their report, Brennan et al.
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showed that it inhibited NF-UB activation in three
cell lines only at a concentration of 1 mM [43,44]. In
the present study, decrease in the levels of nuclear
p65 was observed in the presence of 10 WM PDTC.
The present results support a role for NF-UB in
induction of IGFBP-2 gene in lung alveolar epithelial
cells growth-arrested by oxidants. From these ¢nd-
ings, several comments should be made. First, in
most studies NF-UB has been shown to be involved
in the regulation of cytokine genes; therefore data
reported herein are consistent with an action of
NF-UB in the control of a large variety of genes.
Second, if NF-UB could participate in the activation
of IGFBP-2, it is likely that this is not the only one
factor involved and that other mechanisms are im-
plicated. One critical question which needs to be ad-
dressed is the role of these molecules in the control of
lung alveolar type 2 cell proliferation and how they
may be linked to the key regulators of the cell cycle
machinery which control entry into S phase. These
regulators include the cyclins and their associated
kinases, the cyclin-dependent kinases (CDKs)
[45,46]. Activities of the various G1 CDKs are regu-
lated by a number of factors including the CDK
inhibitors (CKIs) [47]. In previous studies, we have
shown that O2 blocked entry of lung epithelial cells
into S phase by inactivation of cyclin E-CDK2 com-
plexes, which was associated with a dramatic induc-
tion of the CKI p21CIP1 [12]. Recent works suggest
interesting possibilities to link NF-UB to the cell
cycle machinery. First, Yang et al. indicated that
p21CIP1 could increase NF-UB activation [48]. This
is in agreement with data reported by Siebenlist
showing that increased expression of c-Rel favored
growth arrest [22]. This growth arrest was correlated
with inhibition of CDK2 and CDK4 apparently
through transcriptional activation of p21CIP1 by c-
Rel. Recently, Perkins et al. provided some insights
into the mechanisms by which NF-kB and p21CIP
can be associated with growth arrest [49]. They dem-
onstrated interactions between the transcriptional ac-
tivation domain of p65 and the coactivator p300.
This interaction appeared to occur in the amino-ter-
minal region of p300 distinct from a carboxyl-termi-
nal region of p300 required for the binding to the
cyclin E-CDK2 complex. This led them to propose
that p21CIP1, by interacting with cyclin E-CDK2,
may modulate the interactions of NF-UB and CDK
complexes, thus contributing to coordinate transcrip-
tional activation by NF-UB of growth-related genes
and cell cycle progression. These data provide sup-
port to link increase in NF-UB activity, increase in
p21CIP1, and growth arrest in lung epithelial cells
exposed to oxidants.
In the past few years much attention has been
focused on the involvement of IGFBPs in growth
control. In lung epithelial cells IGFBP-2, which is
the predominant form of IGFBPs produced as deter-
mined by ligand blotting experiments, has been
shown to be associated with block of proliferation.
Similar ¢ndings were reported by Park et al. in in-
testinal epithelial cells [50]. In other cell systems,
IGFBP-3 was found to be the main IGFBP produced
and to be associated with growth inhibition [51]. If
these various studies have helped to establish the
involvement of IGFBPs in the control of cell prolif-
eration through either an IGF-dependent or IGF-in-
dependent signaling pathway, it remains now to
understand how IGFBPs can be linked to the cell
cycle machinery and to determine the mechanisms
regulating their expression. At the present time, there
are no reports in the literature on the role of NF-UB
in the transcriptional activation of IGFBPs. The in-
volvement of another factor known to play a central
role in late G1 checkpoint and to act as growth sup-
pressor, the protein p53, has recently been discussed.
In colon carcinoma cells, Buckbinder et al. have pro-
vided data documenting induction of IGFBP-3 in
growth-arrested cells and demonstrating transcrip-
tional regulation of IGFBP-3 by p53 [52]. These ¢nd-
ings support a role for IGFBP-3 in mediating inhib-
itory actions of p53 on cell proliferation.
Interestingly, a link between NF-UB and p53 has
been reported by Wu et al. [53]. These authors pro-
duced direct evidence that NF-UB speci¢cally recog-
nized the NF-UB sites in the p53 promoter and acti-
vated p53. From these various studies, it may be
hypothesized that NF-UB could regulate expression
of several IGFBPs either directly or indirectly
through p53.
To conclude, the data reported herein provide evi-
dence that NF-UB may play a role in the transcrip-
tional regulation of IGFBP-2 in lung alveolar epithe-
lial cells exposed to oxidants. We speculate that
signaling events involving accumulation of NF-UB
levels converge to activate IGFBP-2 in situations as-
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sociated with an imbalance in oxidant-antioxidant
equilibrium and block of proliferation. Dissection
of these signaling pathways should provide insights
into the mechanisms involved in cell cycle regulation
of IGFBP-2 and into the role of IGFBP-2 in the
control of lung epithelial cell proliferation.
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